AMERICAN REBEL HOLDINGS INC (AREB)
US02919L3078 - Common Stock
We assign a fundamental rating of 3 out of 10 to AREB. AREB was compared to 84 industry peers in the Commercial Services & Supplies industry. AREB has a bad profitability rating. Also its financial health evaluation is rather negative. AREB is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
AREB had negative earnings in the past year.
AREB had a negative operating cash flow in the past year.
AREB had negative earnings in each of the past 5 years.
In the past 5 years AREB always reported negative operating cash flow.
1.2 Ratios
With a Return On Assets value of -22.54%, AREB is not doing good in the industry: 85.54% of the companies in the same industry are doing better.
AREB's Return On Equity of -33.53% is on the low side compared to the rest of the industry. AREB is outperformed by 74.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.54% | ||
| ROE | -33.53% | ||
| ROIC | N/A |
ROA(3y)-401.97%
ROA(5y)-360.93%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
AREB has a Gross Margin of 22.01%. This is in the lower half of the industry: AREB underperforms 63.86% of its industry peers.
In the last couple of years the Gross Margin of AREB has declined.
The Profit Margin and Operating Margin are not available for AREB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.15%
GM growth 5Y-17.48%
2. Health
2.1 Basic Checks
AREB does not have a ROIC to compare to the WACC, probably because it is not profitable.
AREB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AREB has been increased compared to 5 years ago.
The debt/assets ratio for AREB has been reduced compared to a year ago.
2.2 Solvency
AREB has an Altman-Z score of -2.20. This is a bad value and indicates that AREB is not financially healthy and even has some risk of bankruptcy.
AREB has a worse Altman-Z score (-2.20) than 89.16% of its industry peers.
AREB has a Debt/Equity ratio of 0.22. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AREB (0.22) is better than 68.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.2 |
ROIC/WACCN/A
WACC10.54%
2.3 Liquidity
AREB has a Current Ratio of 2.23. This indicates that AREB is financially healthy and has no problem in meeting its short term obligations.
AREB has a better Current ratio (2.23) than 73.49% of its industry peers.
AREB has a Quick Ratio of 2.23. This is a bad value and indicates that AREB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of AREB (0.75) is worse than 81.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 0.75 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 94.14% over the past year.
AREB shows a strong growth in Revenue. In the last year, the Revenue has grown by 222.74%.
Measured over the past years, AREB shows a very strong growth in Revenue. The Revenue has been growing by 178.98% on average per year.
EPS 1Y (TTM)94.14%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q89.44%
Revenue 1Y (TTM)222.74%
Revenue growth 3Y150.12%
Revenue growth 5Y178.98%
Revenue growth Q2Q-18.4%
3.2 Future
The Earnings Per Share is expected to grow by 41.94% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 51.23% on average over the next years. This is a very strong growth
EPS Next Y100.4%
EPS Next 2Y41.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year88.12%
Revenue Next 2Y51.23%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
AREB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 3.02, which indicates a rather cheap valuation of AREB.
100.00% of the companies in the same industry are more expensive than AREB, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.49. AREB is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.02 |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AREB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as AREB's earnings are expected to grow with 41.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.94%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for AREB!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMERICAN REBEL HOLDINGS INC
NASDAQ:AREB (4/26/2024, 7:00:00 PM)
After market: 0.3277 -0.01 (-3.25%)0.3387
-0.02 (-5.39%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.02M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 3.02 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -22.54% | ||
| ROE | -33.53% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.01% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.22 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.23 | ||
| Quick Ratio | 0.75 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)94.14%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y100.4%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)222.74%
Revenue growth 3Y150.12%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y